Abstract
The mitochondrial integrity and function in endothelial cells are essential for angiogenesis. TIMM44 (translocase of inner mitochondrial membrane 44) is essential for integrity and function of mitochondria. Here we explored the potential function and the possible mechanisms of TIMM44 in angiogenesis. In HUVECs, human retinal microvascular endothelial cells and hCMEC/D3 brain endothelial cells, silence of TIMM44 by targeted shRNA largely inhibited cell proliferation, migration and in vitro capillary tube formation. TIMM44 silencing disrupted mitochondrial functions in endothelial cells, causing mitochondrial protein input arrest, ATP reduction, ROS production, and mitochondrial depolarization, and leading to apoptosis activation. TIMM44 knockout, by Cas9-sgRNA strategy, also disrupted mitochondrial functions and inhibited endothelial cell proliferation, migration and in vitro capillary tube formation. Moreover, treatment with MB-10 (“MitoBloCK-10”), a TIMM44 blocker, similarly induced mitochondrial dysfunction and suppressed angiogenic activity in endothelial cells. Contrarily, ectopic overexpression of TIMM44 increased ATP contents and augmented endothelial cell proliferation, migration and in vitro capillary tube formation. In adult mouse retinas, endothelial knockdown of TIMM44, by intravitreous injection of endothelial specific TIMM44 shRNA adenovirus, inhibited retinal angiogenesis, causing vascular leakage, acellular capillary growth, and retinal ganglion cells degeneration. Significant oxidative stress was detected in TIMM44-silenced retinal tissues. Moreover, intravitreous injection of MB-10 similarly induced oxidative injury and inhibited retinal angiogenesis in vivo. Together, the mitochondrial protein TIMM44 is important for angiogenesis in vitro and in vivo, representing as a novel and promising therapeutic target of diseases with abnormal angiogenesis.
Similar content being viewed by others
Introduction
Vascular dysfunction is a common pathogenesis mechanism of a number of diseases, such as ischemic stroke, heart failure, diabetes, cancer, and retinal disorders [1, 2]. Oxygen and nutrient shortage following vascular disorder shall cause imbalance of metabolic demand and supply [3, 4], which could initiate angiogenesis process [3, 4]. VEGF (vascular endothelial growth factor) and other growth factors, as well as various cytokines and other factors could also activate endothelial cells and promote angiogenesis [3,4,5,6,7].
Angiogenesis is a dynamic and energy-consuming process [3,4,5,6,7]. To form new blood vessels, endothelial cells in the lumen of blood vessels shall change from the static state to proliferative state [7,8,9]. Mitochondria are endothelial signal centers, which regulate endothelial functions and promote angiogenesis by coordinating energy metabolism, reactive active oxygen (ROS), calcium concentration, and apoptosis [10,11,12].
In addition to providing energy for cells, mitochondria are vital in regulating key cell processes, including cell differentiation, signaling transduction, and apoptosis, as well as cell growth and cell cycle progression [13,14,15,16,17,18]. The functional state of mitochondria is vital for maintaining mitochondrial membrane potential, mitochondrial membrane channel integrity, Ca2+ concentration, respiratory chain complex activity, and ATP synthesis. Mitochondrial dysfunction is mainly manifested in changes in mitochondrial morphology and structure, decreased ATP production, excessive production of ROS and oxidative injury, mtDNA damage and apoptosis activation [16,17,18]. Thus, endothelial mitochondria are key signaling hubs regulating angiogenesis other key endothelial cell functions [11, 19].
Translocase of inner mitochondrial membrane (TIMM) 44, or TIMM44, is a mitochondrial protein locating at the inner mitochondrial membrane [20, 21]. TIMM44 anchors the mitochondrial heat shock protein 70 (mtHsp70) protein to TIMM23 protein complex. This process is ATP-dependent [22,23,24]. TIMM44 modulates mitochondrial pre-proteins’ import to the mitochondrial matrix [22, 23]. This process requires appropriate inner membrane potential and ATP production through mtHsp70 [22, 23]. TIMM44-overexpressed transgenic mice were protected from Type-II diabetes [20]. Mitochondrial genes, including mitofusin-1 (Mfn1), mitofusin-2 (Mfn2), and optic atrophy 1 (Opa1), were upregulated in TIMM44 transgenic mice [20, 25]. TIMM44 overexpression inhibited ROS production and oxidative injury, whereas increasing ATP production [25, 26]. Here we explored the potential function and the possible mechanisms of TIMM44 in angiogenesis in vitro and in vivo.
Materials and methods
Reagents, chemicals, and antibodies
Polybrene, puromycin, medium, and serum were obtained from Sigma-Aldrich (St. Louis, MO). Antibodies for Opa1(#80471), mitofusin-1 (Mfn1, #14739), and mitofusin-2 (Mfn2, #11925) were purchased from Cell Signaling Tech (Danvers, MA). Other antibodies were reported previously [25]. All fluorescence probes were from Thermo-Fisher Invitrogen (Shanghai, China). MB-10 (“MitoBloCK-10”) was reported previously [25].
Cell culture and transfection
Human umbilical vein endothelial cells (HUVECs), human retinal microvascular endothelial cells (hRMECs) and hCMEC/D3 brain endothelial cells were reported in the previous studies [27,28,29,30]. Cells were cultured in described medium and were maintained under the pro-angiogenic state [29, 30].
Gene silencing or overexpression
The lentiviral particles with the TIMM44 shRNA (shTIMM44-seq1/2, two different sequences), the scramble control shRNA, the TIMM44-overexpressing construct, or the empty vector (“Vec”) were described early [25]. The viral particles, at MOI = 15, were added directly to the endothelial cells maintained under the polybrene-containing medium. After 48 h, puromycin-containing medium was added to select stable cells for another 96 h. TIMM44 silencing or overexpression was verified at mRNA and protein levels. Expression of Opa1, Mfn1, or Mfn2 in HUVECs was through the same procedure.
CRISPR/Cas9-induced TIMM44 knockout
Endothelial cells were seeded at 65–70% confluence and were transduced with a Cas9-expressing construct (Genechem, Shanghai, China). The lentiviral particles with the CRISPR/Cas-9 TIMM44 knockout (KO) construct, encoding sgRNA sequence against human TIMM44 (as reported previously [25]), were added directly to Cas9-expressing endothelial cells. After 48 h, puromycin-containing medium was added to select stable cells for additional 96 h. TIMM44 KO in the single stable cells was verified at mRNA and protein levels.
Mitochondrial protein import assay
The detailed protocols were described elsewhere [25, 31]. In brief, the [35S]-methionine plus cysteine-labeled Su9-dihydrofolate reductase (DHFR) fusion protein was utilized [25]. Mitochondria (200 µg/mL) were dissolved to the import buffer [31] and import reaction was started by adding the fusion protein in the mitochondria mix. After 15 min, the import of the fusion protein was terminated. Mitochondria were pelleted, dissolved and input proteins measured via SDS-PAGE and autoradiography [25].
Thiobarbituric acid reactive substance assaying of lipid peroxidation
A commercial thiobarbituric acid reactive substance (TBAR) kit (Cayman Chemical, MI) was utilized to test lipid peroxidation in total cellular lysates (25 μg per sample). The kit specifically quantified lipid peroxidation intensity by colorimetrically measuring malondialdehyde (MDA). The TBAR intensity optical density (OD) was tested at 545 nm with the reference of 600 nm. It was expressed in nmol per mg of total protein, with its value normalized to that of control.
Other cellular functional studies
Nuclear EdU (5-ethynyl-2′-deoxyuridine)/DAPI (4,6-diamidine-2′-phenylindole dihydrochloride) staining (testing cell proliferation), in vitro cell migration “Transwell” assay, in vitro cell invasion “Matrigel Transwell” assay, and in vitro capillary tube formation as well as nuclear TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling)/DAPI staining of cell apoptosis, the Caspase-3 activity assay, JC-1 (tetrachloro-tetraethylbenzimidazolylcarbocyanine iodide) staining of mitochondrial potential and ROS detection by CellROX and DCF-DA (dichlorofluorescein diacetate) staining were described in detail in previous studies [25, 29, 30, 32, 33]. The quantitative real-time PCR (qRT-PCR) and Western blotting were described early [28, 29, 33,34,35,36]. Isolation of mitochondrial fraction lysates and mitochondrial-null lysates was through the described protocol [25, 37]. The cellular ATP contents were examined as described [38]. The mitochondrial complex I activity was tested via a commercial kit (Abcam) [25]. The superoxide dismutase (SOD) activity in fresh mouse retinal tissues was measured by a SOD ELISA kit (Thermo-Fisher Invitrogen, Shanghai, China) using the attached protocols. The uncropped blotting images were shown in Fig. S1.
Animal studies
The adult C57BL/6 mice (hale male half female, 4–5 week old, 18.3–19.2 g) were provided by the SLAC Laboratory Animal Center (Shanghai, China). Mice were maintained under standard conditions and were anesthetized as described [29, 30]. Approximately 0.1 μL AAV or MB-10 (or vehicle control) was intravitreously injected into the vitreous cavity with the needle directly above the optic nerve head [29, 30]. NeuN (Neuronal Nuclei) immunofluorescence staining of retinal ganglion cells (RGCs) in the mouse retinal slides, retinal vasculature detection by isolectin B4 (IB4) staining, retinal trypsin digestion assaying of acellular capillaries, Evans blue (EB) staining of vascular leakage were described in detail in previous studies [29, 30]. The Institutional Animal Care and Use Committee and the Ethic Committee of Soochow University approved the protocols, and animal studies were in according to the ARVO (Association for Research in Vision and Ophthalmology) statement.
Statistical analyses
Data, expressed as means ± standard deviation (SD), were all normally distributed. One-way ANOVA plus a Scheffe’s f-test (for comparison of three or more groups, SPSS 23.0), or the two-tailed unpaired t test (for comparison of two groups, Excel 2007) were utilized to examine significance. P values < 0.05 were considered statistically significant.
Results
TIMM44 silencing inhibits proliferation, migration, and tube formation in cultured endothelial cells
First lentivirus encoding two shRNAs against human TIMM44, shTIMM44-seq1 and shTIMM44-seq2 (with different sequences [25]), were individually transfected to cultured HUVECs, and following selection by puromycin single stable HUVECs formed. TIMM44 mRNA expression decreased over 80% in shTIMM44-expressing HUVECs (Fig. 1A), where TIMM23 mRNA levels were unchanged (Fig. 1A). TIMM44 protein downregulation was detected as well in HUVECs with TIMM44 shRNA (Fig. 1B), and TIMM23 protein expression again unchanged (Fig. 1B). shTIMM44 HUVECs and HUVECs with scramble non-sense control shRNAs (“shC”) were maintained at the pro-angiogenic state under the describe medium [29]. As shown shRNA-induced silencing of TIMM44 inhibited HUVEC proliferation and substantially decreased the percentage of EdU positively-stained nuclei (Fig. 1C). Moreover, in vitro cell migration and invasion, tested separately by “Transwell” (Fig. 1D) and “Matrigel Transwell” (Fig. 1E) assays, were largely inhibited after TIMM44 silencing (Fig. 1D, E). Furthermore, the in vitro capillary tube formation ability was robustly decreased in shTIMM44-expressing HUVECs (Fig. 1F).
To both human retinal microvascular endothelial cells (hRMECs) and hCMEC/D3 brain endothelial cells [29], shTIMM44-seq1-expressing lentivirus were added. Stable cells were formed with puromycin selection. TIMM44 mRNA silencing was detected in shTIMM44-seq1-expresssing endothelial cells (Fig. 1G), and TIMM23 mRNA levels unchanged (Fig. 1H). The nuclear EdU staining assay and “Transwell” assay results revealed that shRNA-induced knockdown of TIMM44 robustly inhibited cell proliferation (Fig. 1I) and migration (Fig. 1J) in the endothelial cells. The in vitro capillary tube formation was also largely inhibited after TIMM44 silencing in hRMECs and hCMEC/D3 cells (Fig. 1K). These results supported that TIMM44 silencing inhibited in vitro angiogenesis in cultured endothelial cells.
TIMM44 silencing disrupts mitochondrial functions in endothelial cells
TIMM44 regulates import of mitochondrial pre-proteins to the mitochondrial matrix [22, 23] and is important for maintaining the integrity and functions of mitochondria, we examined whether TIMM44 silencing altered mitochondrial functions in endothelial cells. In cultured HUVECs, viral shRNA-induced knockdown of TIMM44 (by shTIMM44-seq1 and shTIMM44-seq2, see Fig. 1) substantially reduced mRNA expression of TIMM44-dependent mitochondrial genes, including Opa1, Mfn1 and Mfn2 [20, 25] (Fig. 2A). TIMM44 silencing remarkably suppressed Su9-DHFR fusion protein’s import to the mitochondria (Fig. 2B), and 70–80% mitochondrial protein import reduction was observed after TIMM44 knockdown in HUVECs (Fig. 2B). Moreover, the mitochondrial complex I activity was decreased after TIMM44 silencing (Fig. 2C). Cellular ATP contents were decreased as well in shTIMM44 HUVECs (Fig. 2D).
TIMM44 shRNA induced mitochondrial depolarization and resulted in JC-1 green monomers accumulation in HUVECs (Fig. 2E). Enhanced ROS production and oxidative injury were observed in TIMM44-silenced HUVECs (Fig. 2F, G). The CellROX red fluorescence intensity (Fig. 2F) and the DCF-DA green fluorescence intensity (Fig. 2G) were both substantially increased in shTIMM44 HUVECs. Moreover, TBAR activity assay results suggested enhanced lipid peroxidation in HUVECs with TIMM44 silencing (Fig. 2H).
Further studies revealed that TIMM44 silencing induced moderate but significant apoptosis in HUVECs. Compared to the shC HUVECs, levels of cleaved (Clvd-) caspase-3 and Clvd-poly (ADP-ribose) polymerase (PARP) were increased in HUVECs with shTIMM44-seq1 or shTIMM44-seq2 (Fig. 2I). In addition, the TUNEL positively-stained nuclei ratio was increased in TIMM44-silenced HUVECs, implying apoptosis activation (Fig. 2J). In both hRMECs and hCMEC/D3 cells, TIMM44 silencing by viral shTIMM44-seq1 (see Fig. 1) similarly resulted in ATP depletion (Fig. 2K) and mitochondrial depolarization (increased JC-1 green monomer intensity, Fig. 2L). Supporting ROS production, the CellROX fluorescence intensity was increased in TIMM44-silenced endothelial cells (Fig. 2M). Moderate apoptosis activation, evidenced by increased nuclear TUNEL staining, was observed in the endothelial cells (Fig. 2N). These results clearly supported that TIMM44 silencing disrupted mitochondrial functions in cultured endothelial cells.
TIMM44 KO inhibits pro-angiogenic activity in HUVECs
To further support the role of TIMM44 in endothelial cells, the CRISPR/Cas9 gene-editing method was utilized to knockout TIMM44. Briefly, a lentiviral CRISPR/Cas9-TIMM44-KO construct was stably transduced to Cas9-expressing HUVECs [29], and single stable cells formed by puromycin selection and TIMM44 KO verification. These cells were named as ko-TIMM44 HUVECs, and TIMM44 mRNA (Fig. 3A) and protein (Fig. 3B) expression depleted. TIMM23 mRNA and protein expression, as expected, was unchanged in ko-TIMM44 HUVECs (Fig. 3A, B). The mitochondrial fractions of the HUVECs were isolated and tested. TIMM44 protein was only enriched in the mitochondrial lysates (Fig. 3C), indicated by the presence of the mitochondrial protein VDAC1 (voltage-dependent anion-selective channel 1) (Fig. 3C), but the absence of the nuclear marker protein Lamin-B1 and the cytosol marker protein α-Tubulin (Fig. 3C), Once again, the mitochondrial TIMM44, but not TIMM23, was depleted in ko-TIMM44 HUVECs (Fig. 3C). TIMM44, TIMM23, and VDAC1 were not detected in the mitochondria-null lysates of HUVECs, whereas Lamin-B1 and α-Tubulin were both present (Fig. 3D).
In cultured HUVECs, CRISPR/Cas9-induced TIMM44 KO remarkably attenuated in vitro cell proliferation, migration and invasion, tested separately by nuclear EdU staining (Fig. 3E), “Transwell” (Fig. 3F) and “Matrigel Transwell” (Fig. 3G) assays, respectively. Moreover, TIMM44 KO largely inhibited in vitro capillary tube formation in HUVECs (see quantified results in Fig. 3H). The lentiviral CRISPR/Cas9-KO control construct, Cas9-C, failed to alter TIMM44/TIMM23 expression (Fig. 3A–D) and HUVEC functions (Fig. 3E–H).
TIMM44 KO disrupts mitochondrial functions in HUVECs
We proposed that TIMM44 KO should disrupt mitochondrial functions in endothelial cells. TIMM44-dependent mitochondrial genes, Opa1, Mfn1, and Mfn2, were significantly decreased in ko-TIMM44 HUVECs (Fig. 4A). Moreover, the mitochondrial complex I activity (Fig. 4B) and the ATP contents (Fig. 4C) were decreased following TIMM44 KO in HUVECs. Further studies showed that JC-1 green monomers were significantly increased in ko-TIMM44 HUVECs, indicating mitochondrial depolarization (Fig. 4D). Moreover, ROS contents were increased in TIMM44 KO HUVECs, as the CellROX red fluorescence intensity (Fig. 4E) and DCF-DA green fluorescence intensity (Fig. 4F) were both increased. Increased TBAR intensity implied lipid peroxidation in ko-TIMM44 HUVECs (Fig. 4G). Supporting apoptosis activation, we found that levels of Clvd-caspase-3/Clvd-PARP (Fig. 4H) and the TUNEL-positive nuclei percentage (Fig. 4I) were augmented in TIMM44 KO HUVECs. The Cas9-C control construct failed to disrupt mitochondrial functions (Fig. 4A–G) nor inducing apoptosis (Fig. 4H, I) in HUVECs. Thus, TIMM44 KO disrupted mitochondrial functions and provoked apoptosis in HUVECs.
We also examined whether re-expression of Mfn1, Mfn2, and Opa1 could rescue TIMM44-depleted endothelial cells. Therefore, to the ko-TIMM44 HUVECs, the Opa1-expressing lentiviral construct, the Mfn1-expressing lentiviral construct and the Mfn2-expressing lentiviral construct were consecutively transduced. Stable cells were then formed after selection by puromycin (“ko-TIMM44 + Opa1/Mfn1/Mfn2 Vec”). Mfn1, Mfn2 and Opa1 protein expression was restored in these cells (Fig. S2A). Importantly, re-expression of Mfn1, Mfn2, and Opa1 in HUVECs attenuated TIMM44 depletion-induced ATP reduction (Fig. S2B) and mitochondrial depolarization (Fig. S2C). Moreover, cell proliferation (Fig. S2D), migration (Fig. S2E), invasion (Fig. S2F), and capillary tube formation (Fig. S2G) were partially restored in the “ko-TIMM44 + Opa1/Mfn1/Mfn2 Vec” HUVECs. These results supported that downregulation of Mfn1, Mfn2, and Opa1 should be one important mechanism of TIMM44 depletion-induced angiogenesis inhibition in HUVECs.
The TIMM44 blocker MB-10 inhibits endothelial cell angiogenesis in vitro
MB-10 (“MitoBloCK-10”) binds to a specific pocket in the C-terminal domain of TIMM44, suppressing mitochondrial protein import and disrupting mitochondrial functions [31]. We therefore examined the potential role MB-10 in HUVECs. Treatment with MB-10 failed to alter TIMM44 mRNA (Fig. 5A) and protein (Fig. 5B) expression in HUVECs. TIMM23 mRNA and protein levels were unchanged in MB-10-treated HUVECs (Fig. 5A, B). Yet mRNA and protein expression levels of TIMM44-dependent mitochondrial genes, Opa1, Mfn1, and Mfn2, were downregulated in MB-10-treated HUVECs (Fig. 5C). MB-10 inhibited cell proliferation and reduced EdU-positive nuclei percentage in HUVECs (Fig. 5D). Mover, HUVEC in vitro cell migration (Fig. 5E) and invasion (Fig. 5F) were largely suppressed following treatment of the TIMM44 blocker. The number of formed capillary tubes was also decreased after treatment with MB-10 (Fig. 5G). Analyzing mitochondrial functions, we showed that the TIMM44 blocker reduced the mitochondrial complex I activity (Fig. 5H) and decreased ATP contents (Fig. 5I) in HUVECs. MB-10 resulted mitochondrial depolarization by inducing JC-1 green monomers accumulation (Fig. 5J). In addition, evidenced by the CellROX intensity increase (Fig. 5K), we showed that the TIMM44 blocker provoked ROS production and oxidative injury in HUVECs. Thus, TIMM44 inhibition by MB-10 inhibited endothelial cell functions and angiogenesis.
Ectopic overexpression of TIMM44 augments endothelial cell angiogenesis in vitro
To further verify the role of TIMM44 in endothelial cells, the lentivirus encoding the TIMM44-expressing construct was transfected to cultured HUVECs, and stable oe-TIMM44 HUVECs formed after selection. TIMM44 mRNA (Fig. 6A) and protein (Fig. 6B) levels were indeed robustly elevated in oe-TIMM44 HUVECs, where TIMM23 mRNA (Fig. 6A) and protein (Fig. 6B) expression was unchanged. Opa1, Mfn1, and Mfn2 mRNA and protein levels were elevated in HUVECs with TIMM44 overexpression (Fig. 6C), and ATP contents (Fig. 6D) increased. In HUVECs, oe-TIMM44 promoted cell proliferation and increased EdU-positive nuclei percentage (Fig. 6E). The in vitro cell migration (Fig. 6F) and invasion (Fig. 6G) were accelerated following TIMM44 overexpression in HUVECs. Moreover, the number of formed capillary tubes (per microscope view) was increased in TIMM44-overexpressed HUVECs (Fig. 6H). Thus, TIMM44 overexpression enhanced endothelial cell angiogenesis in vitro. In hRMECs and hCMEC/D3 cells, the application of the lentiviral TIMM44-expressing construct similarly resulted in robust TIMM44 mRNA overexpression (“oe-TIMM44”) (Fig. 6I), without affecting TIMM23 mRNA expression (Fig. 6J). Similar to the results in HUVECs, oe-TIMM44 enhanced cell proliferation (Fig. 6K) and in vitro cell migration (Fig. 6L) of the endothelial cells.
Endothelial knockdown of TIMM44 inhibits retinal angiogenesis in mice
Retinal vasculature could be directly viewed, offering an accessible window to explore the mechanism of angiogenesis [39]. To explore the potential effect of TIMM44 on angiogenesis in vivo, the adult male C57BL/6 mice were intravitreously injected with AAV5-TIE1-TIMM44 shRNA. It contains sequence of TIE1, the endothelial cell-specific promoter, leading to endothelial knockdown of TIMM44 (“TIMM44-EKD”). The control mice were intravitreously injected with AAV5-TIE1-scramble control shRNA (“shC”). Ten days after the virus injection, retinal tissues were separated and tissue lysates were examined. As shown, TIMM44 mRNA (Fig. 7A) and protein (Fig. 7B) expression were significantly decreased in TIMM44-EKD retinal tissues, where TIMM23 mRNA and protein expression was unchanged (Fig. 7A, B). In TIMM44-EKD retinal tissues, Opa1, Mfn1, and Mfn2 mRNA levels were significantly decreased (Fig. 7C). Following endothelial knockdown of TIMM44, the TBAR intensity was significantly increased (Fig. 7D) and SOD activity was decreased (Fig. 7E). These results implied that endothelial knockdown of TIMM44 disrupted mitochondrial functions and provoked oxidative injury in retinal tissues.
Significantly, TIMM44-EKD inhibited retinal angiogenesis in vivo. Retinal IB4 staining assay results, Fig. 7F, showed that TIMM44 shRNA AAV injection suppressed retinal angiogenesis in vivo. TIMM44-EKD retinas showed decreased number of vascular branches and branch points (Fig. 7F). Evans blue (EB) results showed that the vascular leakage was significantly increased in TIMM44 shRNA virus-injected retinas (Fig. 7G). The retinal trypsin digestion assay further demonstrated that the number of acellular capillaries was increased in the TIMM44-EKD retinas (Fig. 7H). Thus, endothelial knockdown of TIMM44 inhibited retinal angiogenesis in mice. These results supported the role of TIMM44 on angiogenesis in vivo.
Endothelial knockdown of TIMM44 results in RGC degeneration in mouse retina
Angiogenesis inhibition will disrupt supply of oxygen, energy, and nutrients, causing neuronal degeneration in retina [40, 41]. It could be the key pathological mechanism of retinal disorders, including retinopathy of prematurity (ROP), diabetic retinopathy (DR), age-related macular degeneration (AMD), and neovascular glaucoma [42]. We therefore analyzed whether endothelial knockdown of TIMM44 could lead to retinal neuronal degeneration. The adult male C57BL/6 mice were intravitreously injected with AAV5-TIE1-TIMM44 shRNA, causing endothelial knockdown of TIMM44 (“TIMM44-EKD”, see Fig. 7). The vertical retinal immunofluorescence assay results demonstrated that NeuN-positive retinal ganglion cells (RGCs) were decreased following TIMM44-EKD (Fig. 8A, B). These results showed that endothelial knockdown of TIMM44 resulted in RGC degeneration in mouse retina.
Intravitreous injection of MB-10 inhibits retinal angiogenesis in vivo
At last, we explored the potential role of MB-10 on angiogenesis in vivo. The adult male C57BL/6 mice were intravitreously injected with MB-10. After 48 h, retinal tissues were tested. As shown, TIMM44 mRNA (Fig. 9A) and protein (Fig. 9B) expression was unchanged in MB-10-injected mouse retinal tissues. TIMM23 mRNA and protein expression was not altered as well (Fig. 9A, B). TIMM44-dependent mRNAs, including Opa1, Mfn1, and Mfn2, were significantly decreased in MB-10-injected retinal tissues (Fig. 9C). Importantly, the TIMM44 blocker caused oxidative injury in retinal tissues, as it increased TBAR intensity (Fig. 9D) but reduced SOD activity (Fig. 9E) in mouse retinal tissues. Retinal angiogenesis was inhibited by intravitreous injection of MB-10 (for 72 h). The quantified EB staining assay results confirmed significantly increased vascular leakage in MB-10-treated retinas (Fig. 9F). Moreover, the relative number of acellular capillaries was increased after treatment with the TIMM44 blocker (Fig. 9G). The retinal immunofluorescence assay results, Fig. 9H, showed that NeuN-positive RGCs were sharply decreased after MB-10 treatment. These results further supported the key role of TIMM44 in angiogenesis in vivo.
Discussion
A previous study has reported an essential role of TIMM44 in cancer growth [25]. TIMM44 expression is elevated in human glioma, whereas TIMM44 silencing or KO potently suppressed glioma cell growth in vitro and in vivo [25]. Mitochondrial dysfunction was observed in TIMM44-depleted glioma cells [25]. The results of the present study supported that TIMM44 is essential for angiogenesis in vitro and in vivo. Silence of TIMM44 by targeted shRNA or Cas9-sgRNA-induced TIMM44 KO largely inhibited endothelial cell proliferation, migration, and in vitro capillary tube formation. MB-10, a TIMM44 blocker, inhibited proliferation, migration, and in vitro capillary tube formation of endothelial cells as well. Contrarily, ectopic overexpression of TIMM44 augmented pro-angiogenic activity in cultured endothelial cells. In mouse retinas, endothelial knockdown of TIMM44, by intravitreous injection of AAV5-TIE1-TIMM44 shRNA, inhibited retinal angiogenesis in vivo, causing vascular leakage and acellular capillary growth.
The mitochondrial integrity and function are essential for angiogenesis [10, 43,44,45,46]. Wang et al. showed that endothelial cell-specific silence of FUN14 domain-containing protein 1 (FUNDC1), a mitochondrial outer-membrane protein, inhibited mitochondria-associated endoplasmic reticulum membrane formation, thereby suppressing VEGFR2 expression, tube formation, spheroid-sprouting, and vessel formation in vitro and in vivo [43]. Ren et al. found that inhibition of pyruvate kinase muscle isoenzyme 2 (PKM2) by C3k in endothelial progenitor cells decreased expression angiogenesis-related genes and inhibited tube formation [45]. Moreover, glycolysis inhibition, mitochondrial membrane potential reduction, ROS production, and oxidative stress were detected in C3k-treated endothelial progenitor cells [45].
We showed that TIMM44 was essential in maintaining mitochondrial functions in endothelial cells. TIMM44 silencing or KO disrupted mitochondrial functions and inhibited mitochondrial protein input, causing mitochondrial complex I activity inhibition and ATP reduction as well as ROS production, mitochondrial depolarization, and apoptosis activation. Moreover, treatment with the TIMM44 blocker MB-10 also induced mitochondrial dysfunction in endothelial cells. Whereas in TIMM44-overexpressed endothelial cells, ATP contents were increased. In mouse retinas, endothelial knockdown of TIMM44 or intravitreous injection of MB-10 induced lipid peroxidation and oxidative injury as well. Thus, TIMM44 depletion/blockage disrupted mitochondrial functions and inhibit angiogenesis in vitro and in vivo.
Studies have discovered that TIMM44-dependent mitochondrial genes, including Mfn1, Mfn2, and Opa1 [20], are important in regulating angiogenesis [10, 44, 46]. Opa1 expression was increased following angiogenic stimuli, thereby inactivating NFκB cascade to increase angiogenic genes expression, eventually promoting angiogenesis [10]. Chen et al. reported that LncRNA Malat1 promoted angiogenesis by increasing Mfn1 expression via silencing miR-26b-5p [44]. Contrarily, endothelial cell silencing of Malat1 downregulated Mfn1 expression, disrupted mitochondrial functions, provoked oxidative stress, and eventually inhibited angiogenesis [44]. Mfn2 is a transmembrane GTPase in the mitochondrial outer membrane. VEGF treatment increased Mfn2 expression in HUVECs. While silence of Mfn2 inhibited VEGF-induced HUVEC migration, indicating a role of Mfn2 in angiogenesis [46].
In the present study, we found that Opa1, Mfn1, and Mfn2 expression was significantly decreased in TIMM44-silenced/-KO endothelial cells. Whereas their expression was upregulated in TIMM44-overexpressed endothelial cells. Moreover, TIMM44 blockage by MB-10 led to downregulation of Opa1, Mfn1, and Mfn2 in endothelial cells. Endothelial cell-specific knockdown of TIMM44, by intravitreous injected with AAV5-TIE1-TIMM44 shRNA, led to Opa1, Mfn1, and Mfn2 mRNA downregulation in retinal tissues. In addition, intravitreous injection of MB-10 downregulated Opa1, Mfn1, and Mfn2 expression in retinal tissues as well. Moreover, we found that re-expression of Mfn1, Mfn2, and Opa1 attenuated mitochondrial aberrations and suppression of the angiogenic process in TIMM44-depelted HUVECs. Thus, TIMM44-driven angiogenesis could be due to promoting Opa1, Mfn1, and Mfn2 expression. Nonetheless, the concrete mechanism of how TIMM44 regulates angiogenesis needs further investigation.
With disruption of retinal angiogenesis, RGC could be degenerated due to lack of oxygen, nutrition, and energy supply and by the inflammatory environment [47,48,49]. This could be a key pathological mechanism of retinal vascular diseases, including DR, AMD, and neo-vascular glaucoma [47,48,49]. We have previously shown that endothelial knockdown of phosphoenolpyruvate carboxykinase 1 (PCK1) suppressed retinal angiogenesis in mouse, causing significant RGC degeneration [29]. In the present study, we found that endothelial knockdown of TIMM44 or intravitreous injection of MB-10 resulted in robust RGC degeneration in mouse retinas. Thus, TIMM44 depletion/blockage inhibited retinal angiogenesis, leading to RGC degeneration in mouse retinas.
Conclusion
Recent studies have supported that mitochondria are essential in maintaining endothelial cell functions [11, 12, 50]. However, mitochondrial proteins that are critical for angiogenesis remain largely unknown [11, 12, 50]. We conclude that the mitochondrial protein TIMM44 is important for angiogenesis in vitro and in vivo. Future studies will be needed to explore other mitochondrial proteins, in this or other cascades, that are vital for the regulation of angiogenesis.
Data availability
All data generated during this study are included in this published article. Data will be made available upon request.
References
Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol. 2017;219:22–96.
Potente M, Makinen T. Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol. 2017;18:477–94.
Eelen G, Treps L, Li X, Carmeliet P. Basic and therapeutic aspects of angiogenesis updated. Circ Res. 2020;127:310–29.
Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011;146:873–87.
Augustin HG, Koh GY. Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology. Science. 2017;357:6353
Betz C, Lenard A, Belting HG, Affolter M. Cell behaviors and dynamics during angiogenesis. Development. 2016;143:2249–60.
Isogai S, Lawson ND, Torrealday S, Horiguchi M, Weinstein BM. Angiogenic network formation in the developing vertebrate trunk. Development. 2003;130:5281–90.
del Toro R, Prahst C, Mathivet T, Siegfried G, Kaminker JS, Larrivee B, et al. Identification and functional analysis of endothelial tip cell-enriched genes. Blood. 2010;116:4025–33.
Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature. 2007;445:776–80.
Herkenne S, Ek O, Zamberlan M, Pellattiero A, Chergova M, Chivite I, et al. Developmental and tumor angiogenesis requires the mitochondria-shaping protein Opa1. Cell Metab. 2020;31:987–1003 e1008.
Marcu R, Zheng Y, Hawkins BJ. Mitochondria and angiogenesis. Adv Exp Med Biol. 2017;982:371–406.
Potente M, Carmeliet P. The link between angiogenesis and endothelial metabolism. Annu Rev Physiol. 2017;79:43–66.
Porporato PE, Filigheddu N, Bravo-San Pedro JM, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2018;28:265–80.
Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015;74:101–10.
Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience. 2007;145:1233–48.
Quiles JM, Gustafsson AB. The role of mitochondrial fission in cardiovascular health and disease. Nat Rev Cardiol. 2022;19:723–36.
Eldeeb MA, Thomas RA, Ragheb MA, Fallahi A, Fon EA. Mitochondrial quality control in health and in Parkinson’s disease. Physiol Rev. 2022;102:1721–55.
Dong T, Chen X, Xu H, Song Y, Wang H, Gao Y, et al. Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases. Pharmacol Ther. 2022;239:108208.
Reichard A, Asosingh K. The role of mitochondria in angiogenesis. Mol Biol Rep. 2019;46:1393–1400.
Wang Y, Katayama A, Terami T, Han X, Nunoue T, Zhang D, et al. Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes. Metab Clin Exp. 2015;64:677–88.
Bonora E, Evangelisti C, Bonichon F, Tallini G, Romeo G. Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. Br J Cancer. 2006;95:1529–36.
Moro F, Okamoto K, Donzeau M, Neupert W, Brunner M. Mitochondrial protein import: molecular basis of the ATP-dependent interaction of MtHsp70 with Tim44. J Biol Chem. 2002;277:6874–80.
Voos W, von Ahsen O, Muller H, Guiard B, Rassow J, Pfanner N. Differential requirement for the mitochondrial Hsp70-Tim44 complex in unfolding and translocation of preproteins. EMBO J. 1996;15:2668–77.
Strub A, Rottgers K, Voos W. The Hsp70 peptide-binding domain determines the interaction of the ATPase domain with Tim44 in mitochondria. EMBO J. 2002;21:2626–35.
Guo YZ, Chen G, Huang M, Wang Y, Liu YY, Jiang Q, et al. TIMM44 is a potential therapeutic target of human glioma. Theranostics. 2022;12:7586–602.
Matsuoka T, Wada J, Hashimoto I, Zhang Y, Eguchi J, Ogawa N, et al. Gene delivery of Tim44 reduces mitochondrial superoxide production and ameliorates neointimal proliferation of injured carotid artery in diabetic rats. Diabetes. 2005;54:2882–90.
Zhang XP, Li KR, Yu Q, Yao MD, Ge HM, Li XM, et al. Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization. FASEB J. 2018;32:3782–91.
Sun J, Huang W, Yang SF, Zhang XP, Yu Q, Zhang ZQ, et al. Galphai1 and Galphai3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis. Theranostics. 2018;8:4695–709.
Yao J, Wu XY, Yu Q, Yang SF, Yuan J, Zhang ZQ, et al. The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo. Sci Adv. 2022;8:eabn6928.
Xu G, Qi LN, Zhang MQ, Li XY, Chai JL, Zhang ZQ, et al. Galphai1/3 mediation of Akt-mTOR activation is important for RSPO3-induced angiogenesis. Protein Cell. 2023;14:217–22.
Miyata N, Tang Z, Conti MA, Johnson ME, Douglas CJ, Hasson SA, et al. Adaptation of a genetic screen reveals an inhibitor for mitochondrial protein import component Tim44. J Biol Chem. 2017;292:5429–42.
Zhang J, Yin DP, Zhang Y, Zhang JN, Yang Y, Zhang ZQ, et al. Identification of Galphai3 as a novel molecular therapeutic target of cervical cancer. Int J Biol Sci. 2022;18:5667–80.
Wang Y, Liu YY, Chen MB, Cheng KW, Qi LN, Zhang ZQ, et al. Neuronal-driven glioma growth requires Galphai1 and Galphai3. Theranostics. 2021;11:8535–49.
Liu YY, Chen MB, Cheng L, Zhang ZQ, Yu ZQ, Jiang Q, et al. microRNA-200a downregulation in human glioma leads to Galphai1 over-expression, Akt activation, and cell proliferation. Oncogene. 2018;37:2890–902.
Shao NY, Wang DX, Wang Y, Li Y, Zhang ZQ, Jiang Q, et al. MicroRNA-29a-3p downregulation causes Gab1 upregulation to promote glioma cell proliferation. Cell Physiol Biochem. 2018;48:450–60.
Cai S, Li Y, Bai JY, Zhang ZQ, Wang Y, Qiao YB, et al. Galphai3 nuclear translocation causes irradiation resistance in human glioma cells. Oncotarget. 2017;8:35061–8.
Liu F, Chen G, Zhou LN, Wang Y, Zhang ZQ, Qin X, et al. YME1L overexpression exerts pro-tumorigenic activity in glioma by promoting Galphai1 expression and Akt activation. Protein Cell. 2023;14:223–9.
Yin DP, Zheng YF, Sun P, Yao MY, Xie LX, Dou XW, et al. The pro-tumorigenic activity of p38gamma overexpression in nasopharyngeal carcinoma. Cell Death Dis. 2022;13:210.
Nguyen TT, Wang JJ, Wong TY. Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care. 2007;30:2708–15.
Rolev KD, Shu XS, Ying Y. Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy. Neuropharmacology. 2021;187:108498.
Zhang J, Liu R, Kuang HY, Gao XY, Liu HL. Protective treatments and their target retinal ganglion cells in diabetic retinopathy. Brain Res Bull. 2017;132:53–60.
Al-Latayfeh M, Silva PS, Sun JK, Aiello LP. Antiangiogenic therapy for ischemic retinopathies. Cold Spring Harb Perspect Med. 2012;2:a006411.
Wang C, Dai X, Wu S, Xu W, Song P, Huang K. FUNDC1-dependent mitochondria-associated endoplasmic reticulum membranes are involved in angiogenesis and neoangiogenesis. Nat Commun. 2021;12:2616.
Chen Y, Li S, Zhang Y, Wang M, Li X, Liu S, et al. The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics. Redox Biol. 2021;41:101910.
Ren R, Guo J, Shi J, Tian Y, Li M, Kang H. PKM2 regulates angiogenesis of VR-EPCs through modulating glycolysis, mitochondrial fission, and fusion. J Cell Physiol. 2020;235:6204–17.
Lugus JJ, Ngoh GA, Bachschmid MM, Walsh K. Mitofusins are required for angiogenic function and modulate different signaling pathways in cultured endothelial cells. J Mol Cell Cardiol. 2011;51:885–93.
Casson RJ, Chidlow G, Crowston JG, Williams PA, Wood JPM. Retinal energy metabolism in health and glaucoma. Prog Retinal Eye Res. 2021;81:100881.
Rutkowski P, May CA. Nutrition and vascular supply of retinal ganglion cells during human development. Front Neurol. 2016;7:49.
Vinores SA, Seo MS, Okamoto N, Ash JD, Wawrousek EF, Xiao WH, et al. Experimental models of growth factor-mediated angiogenesis and blood-retinal barrier breakdown. Gen Pharmacol. 2000;35:233–9.
Dranka BP, Hill BG, Darley-Usmar VM. Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free Radic Biol Med. 2010;48:905–14.
Acknowledgements
This work was generously supported by Natural Science Foundation of Jiangsu Province of China (No: BK20191176), The Jiangsu Province Maternal and Child Health Research Project (No: F202116), Gusu Health Talent Project of Suzhou City (No: GSWS2019052, GSW2020049), National Tutorial System Training Program for key Young Health Talents in Suzhou (No: Qngg2021011), the Scientific Research Project of Jiangsu Health Commission (No: M2022062), Suzhou Science and Technology Development Plan [People’s Livelihood Science and Technology (No: SYS2020161), Suzhou Science and Technology Development Plan [Innovation in medical and health technology (No: SKY2022055, SKY2022173, SKY2022174) and by Suzhou Health Key Talent Project (GSWS 2019016) and National Natural Science Foundation of China (82172520).
Author information
Authors and Affiliations
Contributions
JY, XCao, YZ, and QW conceived, designed, and supervised the study. ZM, HL, SC, SD, XChen, YZ, and QW performed in vitro cellular and in vivo animal experiments and analyzed the data. All authors drafted the article and revised it critically for important intellectual content, and with final approval of the version submitted to the journal.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
This study was approved by the Ethics Committee of Soochow University.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Professor Paolo Pinton
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ma, Zr., Li, HP., Cai, Sz. et al. The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo. Cell Death Dis 14, 307 (2023). https://doi.org/10.1038/s41419-023-05826-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-023-05826-9
- Springer Nature Limited
This article is cited by
-
Identification of the central role of RNA polymerase mitochondrial for angiogenesis
Cell Communication and Signaling (2024)
-
A first-in-class TIMM44 blocker inhibits bladder cancer cell growth
Cell Death & Disease (2024)
-
The requirement of the mitochondrial protein NDUFS8 for angiogenesis
Cell Death & Disease (2024)